WFM
GSK icon

Wolff Financial Management’s GSK GSK Stock Holding History

Wolff Financial Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,457
Closed -$373K – 83
2019
Q2 		$373K Hold
7,457
– – 0.29% 60
2019
Q1 		$390K Hold
7,457
– – 0.32% 58
2018
Q4 		$356K Buy
+7,457
New +$367K 0.35% 58

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wolff Financial Management's GSK Position: Q3 2019 in Review

Wolff Financial Management sold out of GSK (GSK) in Q3 2019, closing a stake of 7,457 shares — an estimated $373K sold.

Wolff Financial Management first reported a position in GSK in Q4 2018 and held it in 3 quarters. The position peaked at $390K in Q1 2019. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Wolff Financial Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Wolff Financial Management sold 7,457 GSK shares in Q3 2019, an estimated $373K.
  • Wolff Financial Management first reported a position in GSK in Q4 2018 and held it in 3 quarters.
  • Wolff Financial Management's GSK position peaked at $390K in Q1 2019.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Wolff Financial Management's 13F filing for Q3 2019, filed 28 Oct 2019.